In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Internal Medicine"
DOI: 10.7326/acpj202001210-004
Abstract: Source Citation Steg PG, Bhatt DL, Simon T, et al. Ticagrelor in patients with stable coronary disease and diabetes. N Engl J Med. 2019;381:1309-20. 31475798 Bhatt DL, Steg PG, Mehta SR, et al. Tic... read more here.
Keywords: stable cad; ticagrelor; type diabetes; cad type ... See more keywords